title: Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes.
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Stephan R
authors.initials: SR
authors.lastname: Bohl
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Anna
authors.initials: A
authors.lastname: Dolnik
authors.affiliation: b Medical Prognosis Institute (MPI) , Hørsholm , Denmark.
authors.forename: Thomas
authors.initials: T
authors.lastname: Jensen
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Katharina M
authors.initials: KM
authors.lastname: Lang
authors.affiliation: c Department of Internal Medicine I , University of Freiburg Faculty of Medicine , Freiburg , Germany.
authors.forename: Björn
authors.initials: B
authors.lastname: Hackanson
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Verena I
authors.initials: VI
authors.lastname: Gaidzik
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Paschka
authors.affiliation: b Medical Prognosis Institute (MPI) , Hørsholm , Denmark.
authors.forename: Steen
authors.initials: S
authors.lastname: Knudsen
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Konstanze
authors.initials: K
authors.lastname: Döhner
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Hartmut
authors.initials: H
authors.lastname: Döhner
authors.affiliation: c Department of Internal Medicine I , University of Freiburg Faculty of Medicine , Freiburg , Germany.
authors.forename: Rainer
authors.initials: R
authors.lastname: Claus
authors.affiliation: c Department of Internal Medicine I , University of Freiburg Faculty of Medicine , Freiburg , Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Lübbert
authors.affiliation: a Department of Internal Medicine III , University Hospital of Ulm , Ulm , Germany.
authors.forename: Lars
authors.initials: L
authors.lastname: Bullinger
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D000077209:Decitabine; D020869:Gene Expression Profiling; D015973:Gene Expression Regulation, Leukemic; D016147:Genes, Tumor Suppressor; D006801:Humans; D053208:Kaplan-Meier Estimate; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D059467:Transcriptome; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D014408:Biomarkers, Tumor; D000077209:Decitabine; D001374:Azacitidine